Press Releases

  • May 19, 2020

    Nemaura Medical 2020 Stock Incentive Plan Approved at Annual General Meeting

    Loughborough, England, May 19, 2020 — Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company...

    May 11, 2020

    Nemaura reports positive data from early head-to-head comparison with a major incumbent CGM Device

    sugarBEAT® was developed as a viable, flexible, and cost-effective alternative to invasive continuous glucose monitors (“CGM”), and the company...

    May 5, 2020

    Nemaura Medical Announces Interview with CEO to Air on May 11

    Loughborough, England, May 5, 2020 — Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company...

    April 21, 2020

    Nemaura Secures $5 Million Loan to Accelerate Commercial Strategy

    Loughborough, England, April 21, 2020 — Nemaura Medical Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company...

    April 1, 2020

    Nemaura Plans To Launch Body-Worn Continuous Temperature Monitor (CTM) to Track Fever Caused by Viral Infections such as COVID-19

    BEAT® platform is planned to be extended to conditions requiring continuous temperature monitoring including viral infections and poor blood...

    March 10, 2020

    Nemaura Medical enters into multiple verbal non-binding agreements for its sugarBEAT® platform

    sugarBEAT® strategic global partnership(s) a step closer as Nemaura Medical enters into multiple verbal non-binding agreements Loughborough, England, March...

    March 3, 2020

    Nemaura Medical Launches sugarBEAT® App on Play Store Ahead of its Planned Commercial Launch of BEAT®diabetes Subscription Service

    sugarBEAT® App is now available on Play Store with iOS app planned to follow, ahead of the planned BEAT®diabetes...

    February 25, 2020

    Nemaura Medical Plans Head-to-Head Study with Major Glucose Monitoring System

    Studies planned to compare sugarBEAT® and major continuous glucose monitor sensor, seeking to position sugarBEAT® as both a possible...

    February 11, 2020

    Nemaura Medical Reports Results and Provides Business Update for the Third Quarter Ended December 31, 2019

    Loughborough, England, Feb. 11, 2020 (GLOBE NEWSWIRE) — – Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura”), a medical technology company...